China Biotech In Review: Cytori Signs $531 Million Deal With New Australian ...

10-11-2013 Seeking AlphaComments (0)

BiotechnologyCytori TherapeuticsLorem Vascular

Lorem Vascular, a new Australian company, will pay as much as $531 million to license southeast Asian rights to a cell therapy system from Cytori Therapeutics (NSDQ: CYTX) of San Diego (see story). The system isolates regenerative cells from the ...

Read more on Seeking Alpha

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top